AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Mylimus 0.1% Ointment

Prescription Icon
Prescription Required

Marketer

Mylan Pharmaceuticals Pvt Ltd - A Viatris Company

Salt Composition

Tacrolimus (0.1% w/w)

Overview Mylimus 0.1% Ointment

Eczema (atopic dermatitis) is treated with Mylimus 0.1% Ointment, which reduces inflammation (skin redness and swelling) by modulating specific immune cells. This soothes itching and improves atopic dermatitis rashes. Apply Mylimus 0.1% Ointment topically, 2–4 times daily to affected skin areas, or as prescribed. Gently and evenly rub it in. Avoid overuse and covering treated areas with bandages. Report to your physician if there's no improvement after two weeks or if your skin condition worsens. Common side effects may include redness, headache, folliculitis, and application site reactions (burning, irritation, itching, redness). Unless medically necessary, this ointment isn't typically advised during pregnancy or breastfeeding.

Primary Ingredients of Mylimus 0.1% Ointment

No text provided. Please provide the text you want me to rephrase.

Uses of Mylimus 0.1% Ointment

Managing atopic eczema

Major Benefits of Mylimus 0.1% Ointment:

Apply this medication topically only. Follow your physician's instructions regarding dosage and treatment length. Always consult the product label for application details. Ensure the affected skin is clean and dry before applying the ointment with a gentle massage.

Common Side effects of Mylimus 0.1% Ointment:

  • Application site reactions (burning, irritation, itching and redness)
  • Headache
  • Hair follicle inflammation

How to use Mylimus 0.1% Ointment:

Apply this medication topically only. Follow your physician's instructions precisely regarding dosage and treatment length. Always consult the product label for application details. Ensure the affected skin is clean and dry before carefully rubbing in the ointment.

How Mylimus 0.1% Ointment works:

Mylimus 0.1% Ointment, an immunosuppressive topical agent, reduces skin inflammation by inhibiting the action of specific immune cells. This alleviates itching and improves the appearance of rashes associated with atopic dermatitis.

SAFETY ADVICE

AlcoholAlcoholNone

No known drug interactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Mylimus 0.1% Ointment during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Application of Mylimus 0.1% Ointment while breastfeeding is likely safe. Available human data indicate minimal risk to the infant.

DrivingDrivingNone

No known drug interactions.

KidneyKidneyNone

No known drug interactions.

LiverLiverNone

No known drug interactions.

What if you forget to take Mylimus 0.1% Ointment :

Should you forget a Mylimus 0.1% Ointment application, use it immediately. If your next scheduled dose is imminent, however, omit the missed application and resume your usual dosing pattern.

Facts to Know About Mylimus 0.1% Ointment

LabelValue
Chemical Category Macrolide Antibiotics
Developing Habits No.
Treatment Category Cancer Medications
Actions Calcineurin inhibitor immunosuppressants

FAQs on Mylimus 0.1% Ointment

Mylimus 0.1% Ointment is an immune-modulating medicine that primarily reduces immune system activity. It treats moderate to severe eczema (atopic dermatitis) in adults whose condition is unresponsive to, or adversely affected by, steroid treatments. Eczema involves an overactive skin immune response causing inflammation, itch, redness, and dryness. Mylimus 0.1% Ointment corrects this abnormal immune response, alleviating inflammation and itching.
Applying Mylimus 0.1% Ointment topically may cause mild to moderate skin irritation, including burning, itching, redness, warmth, pain, altered sensation, and rash. These side effects usually subside within a week. Treatment may also increase the risk of inflamed or infected hair follicles, cold sores, acne, and generalized herpes simplex infections.
Mylimus 0.1% Ointment offers safe and effective short-term atopic dermatitis treatment. Its minimal systemic absorption after topical application results in fewer side effects compared to oral immunosuppressants.
Mylimus 0.1% Ointment is not a controlled substance and does not have abuse potential. Controlled substances require authorization from both a doctor and regulatory authorities due to their potential for misuse.
Prolonged use of Mylimus 0.1% Ointment may increase the risk of lymphoma (a type of lymph node tumor). Studies show a link between Mylimus 0.1% Ointment, or similar medications, and the development of skin cancer or lymphoma in a small number of patients. If using Mylimus 0.1% Ointment for over six weeks, or if your eczema worsens or fails to improve, consult your doctor.
Mylimus 0.1% Ointment is a non-steroid medication that modifies the immune system. Primarily used for eczema, particularly atopic dermatitis, it avoids the skin thinning and other side effects associated with steroids.
Mylimus 0.1% Ointment
597
MRP 691
13% off